{
  "id" : "ss2018_eye_other_36531",
  "algorithm" : "eod_public",
  "version" : "1.1",
  "name" : "SS2018: Eye Other",
  "title" : "Summary Stage 2018: Eye Other",
  "subtitle" : "Summary Stage 2018",
  "notes" : "**Eye Other**\n\n8000-8700, 9700-9701 (C691-C694, C696, C698-C699 )\n8720-8790 (C691-C692, C695-C696, C698-C699)\n\nC691-C696, C698-C699\nC691  Cornea, NOS \nC692  Retina \nC693  Choroid\nC694  Ciliary Body\nC695  Lacrimal Gland\nC696  Orbit, NOS\nC698  Overlapping lesion of eye and adnexa \nC699  Eye, NOS \n\n**Note 1:** The following sources were used in the development of this chapter\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n\n**Note 2:** See the following chapters for the listed histologies \n* C691-C694, C696, C698-C699 (8710-8714, 8800-8921, 8932-8934, 8940-8990, 9000-9016, 9030-9137, 9141-9175, 9181-9230, 9240-9509, 9520-9582): *Orbital Sarcoma*\n* C693, C694 (8720-8790): *Melanoma Uvea*\n* C695 (8000-8700, 8941, 8980, 8982, 9700-9701): *Lacrimal Gland* and *Lacrimal Sac*\n* C695 (8710-8714, 8800-8921, 8932-8934, 8940, 8950-8975, 8981, 8983-8990, 9000-9016, 9030-9137, 9141-9175, 9181-9230, 9240-9509, 9520-9582): *Orbital Sarcoma*\n* 8930-8931, 8991, 9020, 9180, 9231: *Soft Tissue*\n* 8935-8936: *GIST*\n* 9140: *Kaposi Sarcoma*\n* 9510-9514: *Retinoblastoma*\n\n**Note 3:** Summary Stage is the only applicable staging system for this site/histology/schema.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)",
  "last_modified" : "2018-04-19T21:51:25.623Z",
  "definition" : [ {
    "key" : "ss2018",
    "name" : "SS2018",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "0", "In situ: noninvasive, intraepithelial" ], [ "1", "Localized only (localized, NOS)\n- Confined to tissue or organ of origin\n- Intraocular extension" ], [ "2", "Regional by direct extension only\n- Adjacent extraocular extension\n    + Eyelid\n    + Orbit" ], [ "3", "Regional lymph node(s) involved only\n- Cervical, NOS\n    + Mandibular, NOS\n    + Submandibular (submaxillary)\n- Parotid, NOS\n    + Infra-auricular\n    + Preauricular\n- Regional lymph node(s), NOS\n  + Lymph node(s), NOS" ], [ "4", "Regional by BOTH direct extension AND regional lymph node(s) involved\n- Codes (2) + (3)" ], [ "7", "Distant site(s)/lymph node(s) involved\n- Distant site(s) (including further contiguous extension)\n- Distant lymph node(s), NOS\n- Distant metastasis, NOS \n  + Carcinomatosis \n  + Distant metastasis WITH or WITHOUT distant lymph node(s)" ], [ "9", "Unknown if extension or metastasis" ] ]
}